⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5247542 | 0.76 | — | — | |
| SCHEMBL4362776 | 0.67 | — | — | |
| SCHEMBL723129 | 0.67 | — | — | |
| SCHEMBL13719072 | 0.63 | — | — | |
| SCHEMBL838359 | 0.61 | — | — | |
| SCHEMBL1766118 | 0.60 | — | — | |
| SCHEMBL1173252 | 0.60 | — | — | |
| SCHEMBL289020 | 0.60 | — | — | |
| SCHEMBL219662 | 0.60 | — | — | |
| SCHEMBL3217229 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399209-A1 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH (DE) | 2024-07-17 | — | — | EP | claimed |
| CN-117957223-A | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2023036821-A1 | NEW QUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2023-03-16 | — | — | WO | claimed |
| EP-4148052-A1 | NEW QUINOLINE DERIVATIVES | Bayer Animal Health GmbH (DE) | 2023-03-15 | — | — | EP | claimed |
| EP-4399209-A1 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH (DE) | 2024-07-17 | — | — | EP | disclosed |
| CN-117957223-A | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-115397891-B | Polysiloxanes with radiation-crosslinkable and moisture-crosslinkable groups | 瓦克化学股份公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20230167246-A1 | Polysiloxanes with radiation- and moisture-cross-linkable groups | WACKER CHEMIE AG (DE) | 2023-06-01 | — | — | US | disclosed |
| WO-2023036821-A1 | NEW QUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2023-03-16 | — | — | WO | disclosed |
| EP-4148052-A1 | NEW QUINOLINE DERIVATIVES | Bayer Animal Health GmbH (DE) | 2023-03-15 | — | — | EP | disclosed |
| CN-115397891-A | Polysiloxanes with radiation-crosslinkable and moisture-crosslinkable groups | 瓦克化学股份公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-110563717-B | Piperidine CXCR7 receptor modulators | 爱杜西亚药品有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-109563085-B | Piperidine CXCR7 receptor modulators | 爱杜西亚药品有限公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-110563717-A | piperidine CXCR7receptor modulators | 爱杜西亚药品有限公司 | 2019-12-13 | — | — | CN | disclosed |
| EP-1829876-A1 | NITROGENEOUS TRICYCLIC COMPOUND | Asahi Kasei Pharma Corporation (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20060247266-A1 | Nitrogen-containing tricyclic compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2006-11-02 | — | — | US | disclosed |
| US-5484871-A | WATER CROSSLINKABLE | WACKER-CHEMIE GMBH (DE) | 1996-01-16 | — | — | US | disclosed |
| US-5420222-A | Curable organo(poly)siloxane compositions | WACKER-CHEMIE GMBH (DE) | 1995-05-30 | — | — | US | disclosed |